Physician

Fernando Cristobal Diaz, MD

According to 2025 Medicare claims, Fernando Diaz, MD (NPI: 1902333545) practices hematology/oncology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 78503-1271.

Diaz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 94 traditional Medicare patients, billed 10,815 HCPCS/CPT codes, and received $129,475 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 438 prescription claims across 96 beneficiaries totaling $30,332 in drug costs, led by Mirtazapine (Mirtazapine). Open Payments data shows 3 records totaling $61. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $620 to $30,332. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$65K$129K2024 Medicare payment: $129,475 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
20249410,815$129,475

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$30K2017 Drug cost: $620 (USD; Tot_Drug_Cst)2018 Drug cost: $11,971 (USD; Tot_Drug_Cst)2019 Drug cost: $9,323 (USD; Tot_Drug_Cst)2020 Drug cost: $7,152 (USD; Tot_Drug_Cst)2021 Drug cost: $1,236 (USD; Tot_Drug_Cst)2023 Drug cost: $6,480 (USD; Tot_Drug_Cst)2024 Drug cost: $30,332 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171129$620
201824158$11,971
201913113$9,323
2020N/R89$7,152
2021N/R16$1,236
2022N/RN/RN/R
202353142$6,480
202496438$30,332

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3641$95
96372Injection of drug or substance under skin or into muscle1323$11
80053Blood test, comprehensive group of blood chemicals3238$10
36415Insertion of needle into vein for collection of blood sample3752$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3549$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MirtazapineMirtazapine332,270$1,106
FinasterideFinasteride11990$304
Atorvastatin CalciumAtorvastatin Calcium171,350$283
GabapentinGabapentin231,290$192
Sertraline HclSertraline Hcl11750$141

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$61Tempus AI, Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Fernando Cristobal Diaz, MD?

Tedicare shows public-source Medicare data for Fernando Cristobal Diaz, MD (NPI 1902333545), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fernando Cristobal Diaz, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Fernando Cristobal Diaz, MD?

Fernando Cristobal Diaz, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Fernando Cristobal Diaz, MD have Open Payments data?

Fernando Cristobal Diaz, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.